Valganciclovir vs valaciclovir for the prevention of cytomegalovirus inclusion disorders in renal transplant recipients
Latest Information Update: 23 Aug 2013
At a glance
- Drugs Valaciclovir (Primary) ; Valganciclovir
- Indications Cytomegalic inclusion disorders
- Focus Pharmacodynamics; Therapeutic Use
- 11 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
- 23 Aug 2013 New trial record